This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Looking for quick cash solutions? Here are effective ways to find cash in just 3 days to help you out in a pinch.
25,350 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
For the next 10 years, dividend stocks hold next potential with steady income and growth. Discover four dependable na...
The (onon) 2026 earnings call offers critical clues about growth drivers, margin reset, and next steps for investors....
Bloom Energy stock reached a fresh intraday high as data-center demand and green-energy tech advances grab headlines....
When a founder makes a sky‑high forecast, investors scramble. This article breaks down elon musk just made claims abo...
A looming recession can test your retirement plan. Discover three common mistakes to avoid, plus practical steps to s...
SpaceX's potential IPO has investors weighing a massive valuation against current profitability. This article breaks ...
Meta Platforms is pouring billions into AI infrastructure. This piece breaks down why that spending could pay off for...
Carvana’s eye-popping ascent sparked debates about online car shopping and disruption. As Amazon weighs in on automot...
The chatter around a SpaceX IPO has investors buzzing, but hype can blur fundamentals. This guide breaks down what to...
Memory plays a critical role in AI growth, and micron's data center gross margin has surged to industry-leading level...
Dive into how to read myriad genetics (mygn) 2025 earnings transcripts, spot growth drivers, assess risk, and build a...